Preferred Antihistamines for Infants Under 1 Year Old
Recommended First-Line Agent
Cetirizine at 0.25 mg/kg twice daily (approximately 2.5 mg BID for a 10 kg infant) is the only antihistamine with documented safety data, FDA approval, and strong evidence for use in infants aged 6 months to 1 year. 1, 2
Age-Specific Safety Thresholds
Cetirizine should NOT be administered to infants younger than 6 months because safety data are completely lacking in this age group. 1
The critical safety age threshold for cetirizine use is 6 months—this is the youngest age at which any oral antihistamine has been studied and approved. 1
For infants under 6 months with allergic symptoms, non-pharmacologic measures (strict allergen avoidance, supportive care, maternal dietary elimination if breastfeeding) are the only appropriate strategies. 1
Dosing and Formulation
The recommended cetirizine dose for infants 6–11 months is 0.25 mg/kg administered twice daily (total daily dose approximately 5 mg for a 10 kg infant). 1, 3
Liquid formulations are strongly preferred because they provide easier administration and more reliable absorption in infants. 1, 2
Sedation is uncommon at the recommended dose, but monitor closely if higher doses are inadvertently given. 1
A randomized, double-blind, placebo-controlled trial in 69 infants aged 6–11 months demonstrated that cetirizine 0.25 mg/kg twice daily was safe with no increase in adverse events compared to placebo, no QT prolongation, and actually trended toward fewer sleep disturbances than placebo. 3
Alternative Second-Generation Antihistamines
Loratadine is FDA-approved for children ≥2 years (1 teaspoonful = 5 mg once daily for ages 2–5 years per FDA labeling), but it is NOT approved or studied for infants under 2 years. 4
Levocetirizine has been studied in infants 6–11 months at 1.25 mg once daily and was well tolerated, but it remains less commonly used than cetirizine in this age group. 5
Cetirizine and loratadine are the only two antihistamines with FDA approval for children under 5 years, but only cetirizine has approval and safety data down to 6 months of age. 1, 2
Medications That Are Absolutely Contraindicated
First-Generation Antihistamines (Diphenhydramine, Hydroxyzine)
First-generation antihistamines should NEVER be prescribed for routine allergic symptoms in children under 6 years due to significant mortality risk. 1, 2, 6
Between 1969 and 2006, 69 deaths in children under 6 years were linked to antihistamine exposure; 41 deaths occurred in children under 2 years, with diphenhydramine responsible for 33 of those deaths. 1, 2, 6
The FDA and American Academy of Pediatrics explicitly advise against OTC cough-and-cold products containing first-generation antihistamines in children under 6 years. 1, 2, 6
FDA labeling for diphenhydramine states: "Children under 6 years of age: Do not use." 7
First-generation antihistamines produce significant CNS depression, anticholinergic effects, and impaired psychomotor performance that persist even with bedtime-only dosing due to long half-lives. 6
Other Contraindicated Agents
Intranasal antihistamines (azelastine, olopatadine) are approved only for children ≥12 years and must not be used in infants. 1, 2
Oral decongestants (pseudoephedrine, phenylephrine) must be avoided in infants due to severe neuropsychiatric effects and death. 1, 2
Using antihistamines "to make a child sleep" is explicitly contraindicated per FDA labeling. 1, 2
OTC cough-and-cold combination products should be avoided in children under 6 years because of overdose risk from multiple active ingredients. 1, 2, 6
Clinical Algorithm for Infants 6–11 Months
| Clinical Scenario | Recommended Action |
|---|---|
| Mild allergic symptoms (few hives, mild itching, watery eyes) | Cetirizine 0.25 mg/kg twice daily (liquid formulation) [1,3] |
| Moderate symptoms (diffuse hives, no respiratory involvement) | Cetirizine 0.25 mg/kg twice daily + close monitoring; consider pediatric allergy referral [1] |
| Severe symptoms or anaphylaxis (respiratory distress, lip/tongue swelling, hypotension) | Epinephrine 0.15 mg IM immediately (first-line); call 911; cetirizine or diphenhydramine may be added as adjunctive therapy ONLY under direct medical supervision in the emergency department [1,6] |
| Infant <6 months with allergic symptoms | No antihistamine; focus on allergen avoidance, maternal dietary elimination if breastfeeding, and immediate pediatric allergy referral [1] |
Special Considerations
Renal Impairment
In moderate renal impairment (creatinine clearance 10–20 mL/min), reduce the cetirizine dose by 50%. 1
Cetirizine should be avoided entirely in severe renal impairment (creatinine clearance <10 mL/min). 1
Atopic Dermatitis
Oral antihistamines have insufficient evidence to recommend for routine treatment of atopic dermatitis in infants; topical therapies remain first-line. 8
Short-term, intermittent use of sedating antihistamines may be considered for sleep loss secondary to itch, but this should not substitute for proper topical management. 8
Antihistamines should NOT be given to infants with atopic dermatitis for the prevention of wheezing or asthma, as the risk of side effects outweighs uncertain preventive benefits. 6
Allergic Rhinitis
Intranasal corticosteroids are the most effective medication class for controlling all symptoms of allergic rhinitis in children under 2 years, supported by high-quality evidence. 1, 2
When used at recommended doses, intranasal corticosteroids are not associated with clinically significant systemic adverse effects. 1, 2
Recommended treatment algorithm: Start with intranasal corticosteroids as first-line therapy; add cetirizine as a second-line or adjunctive agent if needed. 1, 2
Common Pitfalls to Avoid
Do not assume all second-generation antihistamines have equivalent safety in infants—age-specific safety data must be verified for each agent. 1
Never combine cetirizine with other sedative medications due to additive CNS depression. 1
Do not use diphenhydramine for routine allergy relief, as a sleep aid, or to "calm" an infant—such use is explicitly contraindicated and hazardous. 6
Avoid all OTC cough-and-cold combination products in children under 6 years, as they markedly increase overdose risk from multiple active ingredients and medication-administration errors. 6
Remember that epinephrine is the ONLY first-line treatment for anaphylaxis—antihistamines are purely adjunctive and must never be given alone or delay epinephrine administration. 1, 6